Stock listing

LS Exchange:A2DX1V Zai Lab Ltd. Aktie

German listing (LS Exchange) of Zai Lab Ltd. · home listing HKEX:9688

Follow Zai Lab Ltd. into a list and get an email when it puts out news.

Home listing price · HKEX:9688

$16.39 HKD -1.48 (-8.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:9688

Past year +1.9% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$16.28 – $17.35 HKDNov 20, 2026
Volume
5.63M sharesNov 20, 2026
Market cap
$20.35B HKDAt the close on Nov 20, 2026 · price × 1.24B shares outstanding
52-week range
$12.31 – $21.50 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$111.8M HKDMedian day 5.09M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Zai Lab Ltd. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
HKEX:9688 · Home$16.39 HKD-1.48 (-8.3%)5,634,815$17.35$17.35$16.28$17.87Close on Nov 20, 2026
NASDAQ:ZLAB$21.03 USD-0.89 (-4.1%)1,442,217$20.99$21.15$20.02$21.92Close on Nov 20, 2026
Frankfurt:1ZLB€1.86 EUR-0.11 (-5.6%)—€1.78€1.87€1.78€1.97Close on Nov 20, 2026
Frankfurt:1ZL€18.90 EUR-0.70 (-3.6%)—€18.80€18.90€18.80€19.60Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:9688 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$16.39-1.48-8.3%$17.35$17.35$16.285,634,815
$17.87-0.90-4.8%$18.79$18.79$17.654,677,700
$18.77-0.41-2.1%$18.98$19.38$18.385,938,800
$19.18-1.06-5.2%$19.80$19.80$19.106,839,300
$20.24-0.78-3.7%$20.82$20.82$20.023,443,000
$21.02+0.56+2.7%$20.58$21.24$20.364,826,400
$20.46-1.02-4.7%$20.70$20.74$20.124,265,500
$21.48+0.52+2.5%$21.06$21.50$20.907,042,800
$20.96+2.60+14.2%$19.89$21.08$19.8910,226,265
$18.36+0.19+1.0%$18.09$18.84$17.696,136,930
$18.17+0.16+0.9%$17.80$18.33$17.705,093,470
$18.01+1.14+6.8%$16.94$18.01$16.945,216,011
$16.87-0.41-2.4%$17.10$17.11$16.573,448,060
$17.28-0.09-0.5%$17.41$17.52$17.003,600,900
$17.37-0.31-1.8%$17.68$17.80$17.152,602,800
$17.68-0.51-2.8%$18.19$18.19$17.584,070,800
$18.19+0.01+0.1%$18.24$18.51$18.063,718,303
$18.18-0.59-3.1%$18.99$19.22$18.075,529,500
$18.77+0.99+5.6%$18.96$18.99$18.146,269,500
$17.78-0.06-0.3%$17.56$17.96$16.716,642,800
$17.84-1.94-9.8%$18.89$19.08$17.834,445,700
$19.78+0.92+4.9%$19.74$20.06$19.602,691,100
$18.86+0.26+1.4%$18.70$19.10$18.702,340,500
$18.60+0.65+3.6%$18.34$18.99$18.344,364,600
$17.95+0.47+2.7%$17.48$18.23$17.353,484,500
$17.48-1.51-8.0%$18.26$18.26$17.295,712,100
$18.99-0.32-1.7%$19.50$19.50$18.593,921,528
$19.31+0.06+0.3%$19.50$19.79$19.201,655,500
$19.25+0.06+0.3%$19.30$19.35$18.934,911,800
$19.19-0.70-3.5%$20.00$20.44$19.156,628,200
$19.89-0.91-4.4%$20.00$20.00$19.322,473,840
$20.80+1.73+9.1%$20.40$20.94$19.983,233,448
$19.07-0.58-3.0%$19.49$19.49$18.911,334,500
$19.65-0.99-4.8%$19.88$19.91$19.062,272,610
$20.64+0.26+1.3%$20.48$21.00$20.265,544,000
$20.38+0.46+2.3%$20.12$20.78$20.105,773,500
$19.92+0.08+0.4%$19.89$20.34$19.575,094,600
$19.84-0.14-0.7%$19.70$19.92$19.531,463,000
$19.98-1.08-5.1%$20.88$20.88$19.734,794,778
$21.06-0.10-0.5%$20.84$21.22$20.528,548,722
$21.16+0.22+1.1%$21.00$21.16$20.607,554,700
$20.94+0.36+1.7%$20.54$21.10$19.898,810,300
$20.58+0.88+4.5%$19.98$20.90$19.9414,849,300
$19.70+0.33+1.7%$19.71$19.72$19.353,019,300
$19.37+0.33+1.7%$19.36$19.66$19.205,081,100
$19.04+0.08+0.4%$19.00$19.34$18.873,682,100
$18.96+0.02+0.1%$19.00$19.09$18.594,856,200
$18.94+0.17+0.9%$18.68$19.25$18.6512,212,468
$18.77-1.23-6.2%$19.99$19.99$18.6310,011,700
$20.000.000.0%$20.24$20.38$19.874,651,400
$20.00-0.08-0.4%$20.08$20.22$19.742,990,900
$20.08-0.68-3.3%$20.94$20.94$19.953,060,400
$20.76-0.30-1.4%$21.00$21.40$20.604,331,500
$21.06+0.56+2.7%$20.50$21.16$20.509,979,742
$20.50+1.06+5.5%$19.80$20.94$19.8010,207,929
$19.44-0.36-1.8%$19.80$19.94$19.304,217,900
$19.80-0.88-4.3%$20.50$20.50$19.736,730,600
$20.68-0.44-2.1%$21.00$21.00$20.326,429,400
$21.12+1.02+5.1%$20.32$21.22$20.109,544,212
$20.10-0.30-1.5%$20.40$20.84$20.026,294,137
$20.40+0.58+2.9%$19.82$20.40$19.826,755,613
$19.82-0.52-2.6%$20.30$20.60$19.696,392,413
$20.34-0.36-1.7%$20.54$20.54$19.678,567,200
$20.70+0.38+1.9%$20.90$21.42$20.4817,909,900
Ticker
LS Exchange:A2DX1V
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
LS Exchange
Currency
EUR

What changed lately

Latest news

All Zai Lab Ltd. news

Zai Lab Ltd. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
32 in the last 12 months · 58 in all · newest Nov 12, 2026 · oldest 2025
Calls
22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
Decks
11 decks · latest Oct 23, 2026

Where Zai Lab Ltd. is listed

ListingExchangeCountryCurrency
HKEX:9688 再鼎醫藥 · Home listingHKEXHong KongHKD
NASDAQ:ZLABNASDAQUnited StatesUSD
gettex:1ZLgettexGermanyEUR
BOATS:ZLABBOATSUnited StatesUSD
LS Exchange:A3DJSHLS ExchangeGermanyEUR
OTC:ZAILFOTCUnited StatesUSD
Lang & Schwarz:A3DJSHLang & SchwarzGermanyEUR
gettex:1ZLBgettexGermanyEUR
Tradegate:1ZLBTradegateGermanyEUR
Frankfurt:1ZLBFrankfurtGermanyEUR
BMV:ZLABNBMVMexicoMXN
Frankfurt:1ZLFrankfurtGermanyEUR
Tradegate:1ZLTradegateGermanyEUR
Munich:1ZLBMunichGermanyEUR
Dusseldorf:1ZLDusseldorfGermanyEUR
Dusseldorf:1ZLBDusseldorfGermanyEUR
Lang & Schwarz:A2DX1VLang & SchwarzGermanyEUR
LS Exchange:A2DX1V · This pageLS ExchangeGermanyEUR
Munich:1ZLMunichGermanyEUR
Stuttgart:1ZLStuttgartGermanyEUR
Stuttgart:1ZLBStuttgartGermanyEUR

Valuation

EV/sales 4.6× against a median of 15.2×: 2nd lowest of 7 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$15.96B HKD
P/E
Loss
EV/sales
4.6×
EV/EBITDA
Negative EBITDA
Price/book
4.6×
Gross margin
54.7%
Operating margin
−63.0%
Net margin
−44.9%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Zai Lab Ltd. · HKEX:9688US$2.60BUS$2.04Bn/a4.6×n/a4.6×−44.9%0.0×n/a
Dyne Therapeutics, Inc. · NASDAQ:DYNUS$2.90BUS$1.97Bn/an/an/a3.1×n/a0.2×1.51
Shanghai Junshi Biosciences Co., Ltd. Class A · SSE:688180US$2.88BUS$3.00Bn/a8.0×n/a3.2×−35.0%0.7×n/a
SELLAS Life Sciences Group, Inc. · NASDAQ:SLSUS$2.78BUS$2.65Bn/an/an/a21.1×n/a0.0×2.19
HLB Co., Ltd. · KRX:028300US$2.67BUS$2.67Bn/a36.9×n/a10.4×−219.1%0.2×n/a
Celcuity Inc. · NASDAQ:CELCUS$2.62BUS$1.98Bn/an/an/an/an/an/a1.10
Xencor, Inc. · NASDAQ:XNCRUS$2.50BUS$2.16Bn/a10.8×n/a4.5×−58.8%0.1×1.21
IDEAYA Biosciences, Inc. · NASDAQ:IDYAUS$2.47BUS$1.66Bn/a45.5×n/a2.3×n/a0.0×0.96
MBX Biosciences, Inc. · NASDAQ:MBXUS$2.46BUS$1.98Bn/an/an/a5.2×n/a0.0×1.30
Almirall SA · BME:ALMUS$2.45BUS$2.46B31.1×1.6×7.3×1.5×5.1%0.2×n/a
Keymed Biosciences, Inc. · HKEX:2162US$2.43BUS$2.04Bn/a19.6×n/a4.0×−73.0%0.2×n/a
Median of the othersUS$2.56BUS$2.10B31.1×15.2×7.3×4.0×−58.8%0.2×1.25

Forecasts

Analysts' consensus from EODHD, read Nov 11, 2026. Not 6ix's view and not investment advice.

Price target
21.03 HKD · Analysts' mean
EPS, year to Dec 2026
-0.20 · 2 analysts
Revenue, year to Dec 2026
439.1M · 11 analysts

Team and board

Officers

OfficerRole
Samantha DuFounder, Chairperson and Chief Executive Officer
Yajing ChenChief Financial Officer
Rafael G. AmadoPresident, Head of Global Research and Development
F. Ty EdmondsonChief Legal Officer and Corporate Secretary
Cyan LiuInvestor Relations
Shan HeSenior Vice President, Chief Business Officer

Board

DirectorRole
Samantha DuFounder, Chairperson and Chief Executive Officer
John D. DiekmanBoard Member
Lonnie MoulderBoard Member
Michel VounatsosBoard Member
Nisa LeungBoard Member
Peter WirthBoard Member
Richard GaynorBoard Member
Scott MorrisonBoard Member
William LisBoard Member

Events

Calls

CallWhenStatus
Zai Lab (HKEX:9688) Q3 2026 Earnings CallThu, Nov 05, 2026 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2026 Earnings CallThu, Aug 06, 2026 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q1 2026 Earnings CallThu, May 07, 2026 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q4 2025 Earnings CallThu, Feb 26, 2026 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q3 2025 Earnings CallThu, Nov 06, 2025 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2025 Earnings CallThu, Aug 07, 2025 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q1 2025 Earnings CallThu, May 08, 2025 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q4 2024 Earnings CallThu, Feb 27, 2025 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q3 2024 Earnings CallTue, Nov 12, 2024 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2024 Earnings CallWed, Aug 07, 2024 · 8:00 PM ETReplay
All 22 calls
CallWhenStatus
Zai Lab (HKEX:9688) Q1 2024 Earnings CallThu, May 09, 2024 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q4 2023 Earnings CallWed, Feb 28, 2024 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q3 2023 Earnings CallWed, Nov 08, 2023 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2023 Earnings CallTue, Aug 08, 2023 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q1 2023 Earnings CallWed, May 10, 2023 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q4 2022 Earnings CallThu, Mar 02, 2023 · 9:00 AM ETReplay
Zai Lab (HKEX:9688) Q3 2022 Earnings CallThu, Nov 10, 2022 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2022 Earnings CallWed, Aug 10, 2022 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q1 2022 Earnings CallWed, May 11, 2022 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q4 2021 Earnings CallWed, Mar 02, 2022 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q3 2021 Earnings CallWed, Nov 10, 2021 · 8:00 AM ETReplay
Zai Lab (HKEX:9688) Q2 2021 Earnings CallTue, Aug 10, 2021 · 8:00 AM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · Before open+0.9%
Q2 2026Aug 6, 2026 · Before open+0.8%
Q1 2026May 6, 2026 · Before open−1.7%
Q4 2025Feb 26, 2026 · Before open−3.1%
Q3 2025Nov 6, 2025 · Before open−2.2%
Q2 2025Aug 7, 2025 · Before open−2.0%
Q1 2025May 8, 2025 · Before open−1.3%
Q4 2024Feb 27, 2025 · Before open+4.9%
Q3 2024Nov 12, 2024 · Before open−1.2%
Q2 2024Aug 6, 2024 · After close+6.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+20.8%
Q4 2023Feb 27, 2024 · After close−2.3%
Q3 2023Nov 7, 2023 · After close+4.3%
Q2 2023Aug 7, 2023 · After close−3.1%
Q1 2023May 9, 2023 · After close+1.4%
Q4 2022Mar 1, 2023 · After close+1.7%
Q3 2022Nov 9, 2022 · After close−0.9%
Q2 2022Aug 9, 2022 · After close−6.4%
Q1 2022May 10, 2022 · After close+12.9%
Q4 2021Mar 2, 2022 · Before open−9.8%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck40 slidesOct 23, 2026
Q2 2026 Earnings PresentationEarnings19 slidesAug 6, 2026
Q1 2026 Earnings PresentationEarnings17 slidesMay 7, 2026
Technical Presentation (April 2026)Technical42 slidesApr 20, 2026
44th Annual J.P. Morgan Healthcare Conference 2026Conference22 slidesJanuary 2026
Q3 2025 Earnings PresentationEarnings22 slidesNov 6, 2025
Q2 2025 Earnings PresentationEarnings40 slidesAug 7, 2025
Technical Presentation (November 2021)Technical16 slidesNovember 2021
Technical Presentation (November 2021)Technical17 slidesNovember 2021
Technical Presentation (2020)Technical17 slides2020
All 11 decks
DeckKindSlidesDate
JP Morgan Healthcare Conference 2018Conference20 slidesJan 8, 2018

Open Decks

Financings

RaiseDate
Private placement of new ordinary shares
Closed: HK$17.28 a share
Nov 9, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$18.00 an ADS on Sep 20, 2017.

Price
US$18.00 an ADS
ADSs offered
8,333,333 American depositary shares
Offering size
US$150 million
Underwriters' option
Up to 1,250,000 more ADSs
Underwriters
J.P. Morgan, Citigroup, Leerink Partners · In the order on the cover
ADSs delivered
On or about Sep 22, 2017

Steps

StepWhen
Draft sent to the SEC in confidenceMay 31, 2017
Filed publiclyAug 15, 2017
Amended 3 timesNewest Sep 20, 2017
Shares registered with an exchangeSep 14, 2017
Declared effective by the SECSep 20, 2017
Final prospectus, with the priceSep 21, 2017

Open IPO · From the cover of the final prospectus (424B4) filed Sep 21, 2017

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue460.2M399.0M266.7M215.0M144.3M49.0M13.0M129.0K
Cost of revenue190.5M147.1M95.8M74.0M52.2M16.7M3.75M43.0K
Gross profit269.6M251.9M170.9M141.0M92.1M32.2M9.24M85.9K
Research and development220.9M234.5M265.9M286.4M573.3M222.7M142.2M120.3M39.3M32.1M
Selling, general and administrative277.6M298.7M281.6M259.0M218.8M111.3M70.2M21.6M12.0M6.38M
Operating income-229.4M-282.1M-366.6M-404.4M-700.1M-301.8M-203.2M-141.8M-51.4M-38.5M
Depreciation and amortization15.0M11.9M9.03M8.23M6.49M4.64M3.77M1.65M548.0K198.2K
EBITDA-214.4M-270.3M-357.5M-396.1M-693.6M-297.2M-199.4M-140.1M-50.8M-38.3M
Interest expense5.21M2.25M000181.0K293.0K40.0K
Income before tax-178.5M-257.1M-334.6M-443.3M-704.5M-268.9M-195.1M-139.1M-50.4M-37.5M
Income tax-2.93M00000000
Net income-175.5M-257.1M-334.6M-443.3M-704.5M-268.9M-195.1M-139.1M-50.4M-37.5M
Earnings per share, basic-0.16-0.26-0.35-0.46-0.76-0.35-3.03-2.64-2.32-3.97
Earnings per share, diluted-0.16-0.26-0.35-0.46-0.76-0.35-3.03-2.64-2.32-3.97

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents679.6M449.7M790.2M1.01B964.1M442.1M75.9M63.0M229.7M83.9M
Short-term investments10.0M330.0M16.3M0445.0M744.7M200.0M200.3M
Receivables106.1M85.2M59.2M40.0M47.5M5.17M3.79M90.0K
Inventory74.7M39.9M44.8M31.6M19.0M13.1M6.00M4.00K
Current assets1.02B1.05B939.6M1.12B1.50B1.22B292.5M269.1M230.6M84.1M
Property, plant and equipment47.4M48.0M53.7M57.9M43.1M29.2M21.4M20.5M11.9M1.25M
Total assets1.17B1.19B1.04B1.22B1.61B1.30B355.2M302.0M249.6M88.9M
Accounts payable141.6M100.9M113.0M66.0M126.2M62.6M22.7M37.4M8.97M523.3K
Current liabilities416.2M299.4M203.1M139.8M192.9M98.0M46.6M48.8M12.1M5.17M
Total liabilities456.9M344.9M240.2M174.5M230.0M128.3M60.5M50.9M14.5M5.95M
Shareholders' equity715.5M840.9M796.1M1.05B1.38B1.17B294.7M251.1M235.2M-51.6M
Shares outstanding1.11B1.08B972.2M960.2M955.0M87.8M68.2M58.0M49.9M9.66M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-150.8M-214.9M-198.2M-367.6M-549.2M-216.1M-191.0M-97.5M-32.4M-32.2M
Capital spending-8.10M-5.66M-7.21M-24.6M-18.3M-10.1M-6.04M-10.0M-9.10M-2.22M
Free cash flow-158.9M-220.5M-205.4M-392.2M-567.5M-226.2M-197.0M-107.6M-41.5M-34.4M
Cash from investing307.9M-375.2M-10.8M420.0M250.0M-554.8M-14.9M-212.6M-10.4M-2.73M
Cash from financing72.4M349.9M-6.43M-1.73M820.2M1.13B219.3M144.1M187.9M106.2M
Change in cash229.9M-240.5M-218.0M44.4M522.0M366.4M13.5M-166.7M145.7M70.8M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
4 · Change in ownershipNov 13, 2026Insider tradeSEC
Next Day Disclosure ReturnNov 12, 2026Next day disclosure returnHKEX
GRANT OF SHARE OPTIONS AND RESTRICTED SHARE UNITSNov 10, 2026Other filingsHKEX
DNov 9, 2026Other filingsSEC
(REVISED) MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2026Nov 9, 2026Monthly returnHKEX
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2026Nov 5, 2026Monthly returnHKEX
OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-QNov 5, 2026Quarterly reportHKEX
UNAUDITED RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2026 AND CORPORATE UPDATESNov 5, 2026ResultsHKEX
Show 200 filings
FilingDateTypeFiled with
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
Next Day Disclosure ReturnOct 28, 2026Next day disclosure returnHKEX
VOLUNTARY ANNOUNCEMENT - CLOSING OF THE PRIVATE PLACEMENT OF AMERICAN DEPOSITARY SHARESOct 28, 2026FinancingHKEX
NOTICE OF AUDIT COMMITTEE ACTIONOct 23, 2026ResultsHKEX
INSIDE INFORMATION - UPDATE ON FIRST DATA FROM GLOBAL PHASE 1B CLINICAL TRIALOct 23, 2026Other filingsHKEX
OVERSEAS REGULATORY ANNOUNCEMENT - FORM 8-KOct 23, 2026Other filingsHKEX
8-K · Current reportOct 23, 2026Material contractSEC
PRIVATE PLACEMENT OF AMERICAN DEPOSITARY SHARES AND ISSUANCE OF UNDERLYING SHARES UNDER GENERAL MANDATEOct 22, 2026FinancingHKEX
CHARTER OF THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEEOct 20, 2026Other filingsHKEX
4 · Change in ownershipOct 5, 2026Insider tradeSEC
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2026Oct 5, 2026Monthly returnHKEX
4 · Change in ownershipAug 21, 2026Insider tradeSEC
144 · Notice of proposed saleAug 20, 2026Other filingsSEC
144 · Notice of proposed saleAug 19, 2026Other filingsSEC
4 · Change in ownershipAug 18, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
4 · Change in ownershipAug 13, 2026Insider tradeSEC
144 · Notice of proposed saleAug 12, 2026Other filingsSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
4 · Change in ownershipJul 1, 2026Insider tradeSEC
144 · Notice of proposed saleJun 30, 2026Other filingsSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
4 · Change in ownershipJun 29, 2026Insider tradeSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
144 · Notice of proposed saleJun 26, 2026Other filingsSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
144 · Notice of proposed saleJun 22, 2026Other filingsSEC
8-K · Current reportJun 17, 2026Meeting outcomeSEC
SCHEDULE 13G · Big-stake noticeJun 11, 2026Big-stake noticeSEC
4 · Change in ownershipJun 8, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 8, 2026Insider tradeSEC
4 · Change in ownershipMay 28, 2026Insider tradeSEC
8-K · Current reportMay 21, 2026Management or board changeSEC
4 · Change in ownershipMay 21, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
144 · Notice of proposed saleMay 18, 2026Other filingsSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
4 · Change in ownershipMay 15, 2026Insider tradeSEC
144 · Notice of proposed saleMay 15, 2026Other filingsSEC
144 · Notice of proposed saleMay 14, 2026Other filingsSEC
144 · Notice of proposed saleMay 14, 2026Other filingsSEC
144 · Notice of proposed saleMay 13, 2026Other filingsSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 28, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 17, 2026Meeting noticeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 6, 2026Big-stake noticeSEC
144 · Notice of proposed saleApr 6, 2026Other filingsSEC
144 · Notice of proposed saleApr 6, 2026Other filingsSEC
144 · Notice of proposed saleApr 6, 2026Other filingsSEC
144 · Notice of proposed saleApr 6, 2026Other filingsSEC
144 · Notice of proposed saleApr 6, 2026Other filingsSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
4 · Change in ownershipApr 3, 2026Insider tradeSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
144 · Notice of proposed saleApr 2, 2026Other filingsSEC
4 · Change in ownershipMar 19, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
144 · Notice of proposed saleMar 13, 2026Other filingsSEC
4 · Change in ownershipMar 12, 2026Insider tradeSEC
144 · Notice of proposed saleMar 11, 2026Other filingsSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
144 · Notice of proposed saleMar 9, 2026Other filingsSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
144 · Notice of proposed saleMar 6, 2026Other filingsSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
144 · Notice of proposed saleMar 5, 2026Other filingsSEC
144 · Notice of proposed saleMar 4, 2026Other filingsSEC
144 · Notice of proposed saleMar 3, 2026Other filingsSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 10, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
4 · Change in ownershipJan 2, 2026Insider tradeSEC
144 · Notice of proposed saleDec 31, 2025Other filingsSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
144 · Notice of proposed saleDec 16, 2025Other filingsSEC
4 · Change in ownershipDec 12, 2025Insider tradeSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 21, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 12, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 5, 2025Big-stake noticeSEC
4 · Change in ownershipNov 4, 2025Insider tradeSEC
144 · Notice of proposed saleNov 3, 2025Other filingsSEC
8-K · Current reportOct 16, 2025Material contractSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
144 · Notice of proposed saleOct 2, 2025Other filingsSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 19, 2025Insider tradeSEC
4 · Change in ownershipAug 18, 2025Insider tradeSEC
144 · Notice of proposed saleAug 18, 2025Other filingsSEC
144 · Notice of proposed saleAug 18, 2025Other filingsSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
144 · Notice of proposed saleAug 15, 2025Other filingsSEC
4 · Change in ownershipAug 14, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2025Big-stake noticeSEC
144 · Notice of proposed saleAug 13, 2025Other filingsSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
4 · Change in ownershipAug 12, 2025Insider tradeSEC
144 · Notice of proposed saleAug 12, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleAug 11, 2025Other filingsSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
144 · Notice of proposed saleAug 8, 2025Other filingsSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 6, 2025Big-stake noticeSEC
4 · Change in ownershipJul 7, 2025Insider tradeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
144 · Notice of proposed saleJul 2, 2025Other filingsSEC
4 · Change in ownershipJul 1, 2025Insider tradeSEC
144 · Notice of proposed saleJun 30, 2025Other filingsSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
4 · Change in ownershipJun 27, 2025Insider tradeSEC
144 · Notice of proposed saleJun 26, 2025Other filingsSEC
144 · Notice of proposed saleJun 26, 2025Other filingsSEC
144 · Notice of proposed saleJun 26, 2025Other filingsSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
4 · Change in ownershipJun 23, 2025Insider tradeSEC
144 · Notice of proposed saleJun 20, 2025Other filingsSEC
8-K · Current reportJun 18, 2025Meeting outcomeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
144 · Notice of proposed saleJun 2, 2025Other filingsSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
144 · Notice of proposed saleMay 14, 2025Other filingsSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
4 · Change in ownershipMay 13, 2025Insider tradeSEC
144 · Notice of proposed saleMay 13, 2025Other filingsSEC
144 · Notice of proposed saleMay 12, 2025Other filingsSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2025Big-stake noticeSEC
144 · Notice of proposed saleMay 9, 2025Other filingsSEC
144 · Notice of proposed saleMay 9, 2025Other filingsSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC

This page holds 200 of 757 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Zai Lab Ltd.’s releases · as of Nov 9, 2026

Common shares
1,241,451,110
Fully diluted
1,241,451,110

Fully diluted

LineShares
Common shares1,241,451,110

Share count over time

CountShares
Nov 22, 20261,241,451,110

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Rtw Investments, LP10.4MUS$273MSep 30, 2026
TCG Crossover Management, LLC6.23MUS$164MSep 30, 2026
Woodline Partners LP5.3MUS$140MSep 30, 2026
ADAR1 Capital Management, LLC3.38MUS$89.1MSep 30, 2026
Ra Capital Management, L.P.2.82MUS$74.2MSep 30, 2026
Goldman Sachs1.91MUS$50.4MSep 30, 2026
Frazier Life Sciences Management, L.P.1.9MUS$50.1MSep 30, 2026
Two Sigma1.81MUS$47.6MSep 30, 2026
Bamco Inc1.58MUS$41.7MSep 30, 2026
Soleus Capital Management, L.P.1.54MUS$40.6MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Citadel1.29MUS$34MSep 30, 2026
Fidelity1.07MUS$28.2MSep 30, 2026
Spruce Street Capital LP1.04MUS$27.5MSep 30, 2026
TD994KUS$26.2MSep 30, 2026
Rock Springs Capital Management LP791KUS$20.8MSep 30, 2026
BlackRock777KUS$20.5MSep 30, 2026
Patient Square Capital LP592KUS$15.6MSep 30, 2026
C WorldWide Group Holding A/S510KUS$13.4MSep 30, 2026
D. E. Shaw & Co., Inc.504KUS$13.3MSep 30, 2026
B Group, Inc.451KUS$11.9MSep 30, 2026
Jane Street438KUS$11.5MSep 30, 2026
Superstring Capital Management LP363KUS$9.55MSep 30, 2026
Nantahala Capital Management, LLC330KUS$8.69MSep 30, 2026
Nan Fung Trinity (Hk) LTD294KUS$7.74MSep 30, 2026
Hennion & Walsh Asset Management, Inc.263KUS$6.93MSep 30, 2026
NEXTBio Capital Management LP238KUS$6.28MSep 30, 2026
Point72 Asset Management, L.P.231KUS$6.07MSep 30, 2026
BNP Paribas203KUS$5.34MSep 30, 2026
Ameriprise195KUS$5.14MSep 30, 2026
Trexquant Investment LP173KUS$4.56MSep 30, 2026
Tidal Investments LLC165KUS$4.33MSep 30, 2026
abrdn156KUS$4.1MSep 30, 2026
Alps Advisors Inc149KUS$3.92MSep 30, 2026
Schroders124KUS$3.21MSep 30, 2026
State Street120KUS$3.17MSep 30, 2026
Seven Fleet Capital Management LP118KUS$3.12MSep 30, 2026
Virtus Investment Advisers, LLC98,741US$2.6MSep 30, 2026
Quadrature Capital Ltd88,632US$2.33MSep 30, 2026
Bank of America84,359US$2.22MSep 30, 2026
Tower Research Capital LLC (TRC)77,723US$2.05MSep 30, 2026
Schonfeld Strategic Advisors LLC75,089US$1.98MSep 30, 2026
Legal & General71,461US$1.88MSep 30, 2026
Gsa Capital Partners LLP71,114US$1.87MSep 30, 2026
XTX Topco Ltd69,668US$1.84MSep 30, 2026
Renaissance Technologies69,400US$1.83MSep 30, 2026
Caption Management, LLC65,796US$1.73MSep 30, 2026
Geode Capital57,946US$1.53MSep 30, 2026
Morgan Stanley50,690US$1.34MSep 30, 2026
Balyasny Asset Management L.P.41,398US$1.09MSep 30, 2026
UBS38,057US$1MSep 30, 2026

This page holds 50 of 101 holders. Open Shareholders

Funds

HolderSharesValueAs of
Vanguard Health Care Fund36.4MUS$66.4MJul 31, 2026
Vanguard Total International Stock Index Fund15.6MUS$28.4MJul 31, 2026
Vanguard Emerging Markets Stock Index Fund15.1MUS$27.5MJul 31, 2026
Baron Emerging Markets Fund13.7MUS$26MJun 30, 2026
iShares Core MSCI Emerging Markets ETF11.9MUS$20.9MMay 31, 2026
Fidelity Series Emerging Markets Opportunities Fund7.71MUS$14.1MJul 31, 2026
Fidelity Emerging Markets Discovery Fund7.58MUS$13.8MJul 31, 2026
Strategic Advisers Fidelity Emerging Markets Fund7.4MUS$13.1MMay 31, 2026
iShares Biotechnology ETF6.35MUS$12MJun 30, 2026
Fidelity China Region Fund4.52MUS$8.23MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Fidelity Growth Company Fund3.33MUS$5.88MMay 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund2.5MUS$4.55MJul 31, 2026
Strategic Advisers Emerging Markets Fund2.05MUS$3.62MMay 31, 2026
Tema Oncology ETF1.97MUS$3.48MMay 31, 2026
iShares Core MSCI Total International Stock ETF1.74MUS$3.17MJul 31, 2026
Fidelity Growth Company K6 Fund1.32MUS$2.33MMay 31, 2026
Schwab Emerging Markets Equity ETF1.22MUS$2.17MMay 31, 2026
ALPS Medical Breakthroughs ETF1.15MUS$2.03MMay 31, 2026
State Street(R) SPDR(R) Portfolio Emerging Markets ETF1.12MUS$2.07MJun 30, 2026
Vanguard Total World Stock Index Fund941KUS$1.71MJul 31, 2026
Fidelity Emerging Markets Equity Central Fund825KUS$1.55MJun 30, 2026
Baron International Growth Fund820KUS$1.55MJun 30, 2026
Virtus Biotech Etf797KUS$1.45MJul 31, 2026
Fidelity Series Growth Company Fund779KUS$1.37MMay 31, 2026
Destinations International Equity Fund758KUS$1.34MMay 31, 2026
College Retirement Equities Fund - Total Global Stock Account742KUS$1.39MJun 30, 2026
Emerging Markets Core Equity 2 Portfolio715KUS$1.3MJul 31, 2026
Fidelity Total International Index Fund663KUS$1.21MJul 31, 2026
The Emerging Markets Small Cap Series573KUS$1.04MJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF494KUS$901KJul 31, 2026
Dimensional Emerging Core Equity Market ETF428KUS$780KJul 31, 2026
iShares MSCI China Small-Cap ETF423KUS$744KMay 31, 2026
WisdomTree China ex-State-Owned Enterprises Fund326KUS$601KJun 30, 2026
Fidelity ZERO International Index Fund318KUS$579KJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio264KUS$488KJun 30, 2026
Fidelity Nasdaq Composite Index Fund239KUS$422KMay 31, 2026
iShares MSCI Emerging Markets Small-Cap ETF220KUS$387KMay 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF217KUS$396KJul 31, 2026
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund212KUS$391KJun 30, 2026
Invesco Golden Dragon China ETF204KUS$372KJul 31, 2026
Vanguard ESG International Stock ETF199KUS$350KMay 31, 2026
Fidelity Disruptive Medicine ETF153KUS$270KMay 31, 2026
Emerging Markets Social Core Equity Portfolio151KUS$274KJul 31, 2026
Fidelity Series Emerging Markets Fund144KUS$262KJul 31, 2026
Baron Emerging Markets Select ETF143KUS$265KJun 30, 2026
State Street(R) SPDR(R) S&P(R) China ETF125KUS$231KJun 30, 2026
Fidelity Flex International Index Fund111KUS$202KJul 31, 2026
Franklin FTSE China ETF97,600US$180KJun 30, 2026
Dimensional Emerging Markets Sustainability Core 1 ETF93,600US$171KJul 31, 2026
Blackstone Alternative Multi-Strategy Fund71,188US$135KJun 30, 2026

This page holds 50 of 68 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Gaynor Richard
Director
Buy1,228USD 27.19US$33,389Nov 10, 2026
Chen Yajing
Officer: Chief Financial Officer
Sale260USD 27.00US$7,020Aug 19, 2026
Lis William
Director
Sale8,506USD 25.00US$213KAug 12, 2026
Chen Yajing
Officer: Chief Financial Officer
Sale619USD 25.00US$15,475Aug 11, 2026
Gaynor Richard
Director
Buy1,736USD 19.05US$33,071Jul 1, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale7,026USD 18.53US$130KJun 30, 2026
Chen Yajing
Officer: Chief Financial Officer
Sale2,264USD 17.46US$39,529Jun 26, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale24,543USD 17.46US$429KJun 26, 2026
Edmondson Frazor Titus III
Officer: Chief Legal Officer
Sale4,103USD 17.46US$71,638Jun 26, 2026
Lis William
Director
Sale7,040USD 18.09US$127KJun 22, 2026
All 26 trades
TradeTradeSharesPriceValueDate
Du Ying
Director, Officer: Chairperson & CEO
Sale50,000USD 19.00US$950KMay 18, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale50,000USD 20.74US$1.04MMay 15, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale50,000USD 20.09US$1MMay 14, 2026
Edmondson Frazor Titus III
Officer: Chief Legal Officer
Sale3,517USD 20.19US$71,008May 14, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale16,231USD 19.44US$316KMay 13, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale33,769USD 20.22US$683KMay 13, 2026
Amado Rafael
Officer: See Remarks
Sale2,739USD 20.45US$56,013Apr 6, 2026
Chen Yajing
Officer: Chief Financial Officer
Sale853USD 20.45US$17,444Apr 6, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale2,653USD 20.45US$54,254Apr 6, 2026
Edmondson Frazor Titus III
Officer: Chief Legal Officer
Sale1,224USD 20.45US$25,031Apr 6, 2026
Smiley Joshua L
Officer: See Remarks
Sale3,017USD 20.45US$61,698Apr 6, 2026
Amado Rafael
Officer: See Remarks
Sale9,910USD 20.39US$202KApr 2, 2026
Chen Yajing
Officer: Chief Financial Officer
Sale5,199USD 20.39US$106KApr 2, 2026
Du Ying
Director, Officer: Chairperson & CEO
Sale5,576USD 20.39US$114KApr 2, 2026
Edmondson Frazor Titus III
Officer: Chief Legal Officer
Sale4,194USD 20.39US$85,516Apr 2, 2026
Smiley Joshua L
Officer: See Remarks
Sale9,614USD 20.39US$196KApr 2, 2026

Big stakes

StakeStakeSharesDateFiling
Rtw Investments, LP9.20%104MSep 30, 2026Schedule 13G
Chen Yu5.30%59.1MJun 2, 2026Schedule 13G
Janus Henderson Group PLC3.60%39.5MMar 31, 2025Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Leon O Moulder Jr
Other companies: Zenas BioPharma, Inc. (See Remarks, Director · Since at least Sep 12, 2024); Dianthus Therapeutics, Inc. (Director · Sep 11, 2023 – May 23, 2024 · Past); Trevena, Inc. (Director · May 16, 2018 – Jun 15, 2023 · Past); Tesaro Inc (Chief Executive Officer, Director · Mar 1, 2018 – Jan 22, 2019 · Past)
Director · Since at least Jan 1, 2021
Alan Sandler
Other companies: Revolution Medicines, Inc. (Chief Development Officer · Since at least Nov 5, 2025); ALX Oncology Holdings Inc. (Director · Since at least Aug 5, 2024); Elevation Oncology Inc (Director · Since at least Feb 29, 2024)
Head of Global Dev., Oncology · Jan 1, 2021 – Jun 25, 2022 · Past
Rafael G. Amado
Other companies: Poseida Therapeutics Inc (Director · Apr 13, 2023 – Jan 8, 2025 · Past); Allogene Therapeutics, Inc. (EVP of R&D · Sep 3, 2019 – Oct 7, 2022 · Past); Adaptimmune Therapeutics PLC (President, R&D · Jan 1, 2016 – Aug 6, 2019 · Past)
President, Head of Global Research and Development · Since at least Dec 30, 2022
William Lis
Other companies: Jasper Therapeutics, Inc. (Director · Sep 24, 2021 – Oct 13, 2023 · Past); Eidos Therapeutics Inc (Director · Dec 4, 2018 – Jan 26, 2021 · Past); Portola Pharmaceuticals Inc (Chief Executive Officer, Director · May 21, 2013 – Jul 28, 2018 · Past)
Board Member · Since at least Jan 1, 2021
Michel Vounatsos
Other companies: Revvity, Inc. (Director · Since at least Mar 1, 2020); Biogen Inc. (Director · Apr 18, 2016 – Nov 5, 2026 · Past)
Director · Since at least Jan 7, 2023
Peter Wirth
Other companies: Forma Therapeutics Holdings Inc (Director · Jun 8, 2022 – Oct 14, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Jun 5, 2024 · Past)
Director · Since at least Dec 8, 2021
Scott Morrison
Other companies: IDEAYA Biosciences, Inc. (Director | Partner, Ernst & Young (retired) · Since at least Nov 4, 2026); Tarsus Pharmaceuticals, Inc. (Director · Since at least Jun 12, 2026)
Board Member · Since at least Jun 17, 2026
John D. Diekman
Other companies: IDEAYA Biosciences, Inc. (Director · May 22, 2019 – Sep 24, 2019 · Past)
Board Member · Since at least Jan 1, 2021
Lonnie Moulder
Other companies: Zenas BioPharma, Inc. (Chief Executive Officer and Chairman of the Board of Directors · Since at least Aug 13, 2026)
Board Member · Since at least Nov 5, 2026
Richard B. Gaynor
Other companies: Alkermes plc (Director · Since at least Dec 2, 2020)
Director · Since at least Nov 19, 2021
All 22 people
PersonSeat
Cyan LiuInvestor Relations · Since at least Jul 22, 2026
Frazor Titus Edmondson IIIChief Legal Officer · Since at least Jan 1, 2021
F. Ty EdmondsonChief Legal Officer and Corporate Secretary · Since at least Nov 5, 2026
Joshua L SmileySee Remarks · Since at least Aug 1, 2022
Kai-Xian ChenDirector · Jan 1, 2021 – Dec 31, 2024 · Past
Nisa LeungBoard Member · Since at least Jun 22, 2026
Samantha DuFounder, Chairperson and Chief Executive Officer · Since at least May 7, 2026
Shan HeSenior Vice President, Chief Business Officer · Since at least Nov 5, 2026
William Ki Chul ChoChief Financial Officer · Jan 1, 2021 – Apr 3, 2023 · Past
Yajing ChenChief Financial Officer · Since at least Apr 1, 2026
Ying DuChairperson & CEO, Director · Since at least Jan 1, 2021
Yizhe WangOperating Partner · Since at least Apr 27, 2026

Open People

Log in to ask 6ix AI your own questions about Zai Lab Ltd.